SAB1407304-50UG Display Image

Anti-FBXO4 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution

Code: SAB1407304-50UG D2-231

General description

This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins const...


read more

Your Price
£432.00 50UG
£518.40 inc. VAT

General description

This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. Alternative splicing of this gene generates 2 transcript variants. (provided by RefSeq)

Immunogen

FBXO4 (NP_036308.1, 1 a.a. ~ 387 a.a) full-length human protein.SequenceMAGSEPRSGTNSPPPPFSDWGRLEAAILSGWKTFWQSVSKERVARTTSREEVDEAASTLTRLPIDVQLYILSFLSPHDLCQLGSTNHYWNETVRDPILWRYFLLRDLPSWSSVDWKSLPDLEILKKPISEVTDGAFFDYMAVYRMCCPYTRRASKSSRPMYGAVTSFLHSLIIQNEPRFAMFGPGLEELNTSLVLSLMSSEELCPTAGLPQRQIDGIGSGVNFQLNNQHKFNILILYSTTRKERDRAREEHTSAVNKMFSRHNEGDDQQGSRYSVIPQIQKVCEVVDGFIYVANAEAHKRHEWQDEFSHIMAMTDPAFGSSGRPLLVLSCISQGDVKRMPCFYLAHELHLNLLNHPWLVQDTEAETLTGFLNGIEWILEEVESKRAR

Physical form

Solution in phosphate buffered saline, pH 7.4

antibody formpurified immunoglobulin
antibody product typeprimary antibodies
biological sourcemouse
clonepolyclonal
conjugateunconjugated
formbuffered aqueous solution
Gene Informationhuman ... FBXO4(26272)
mol wtantigen ~44.1 kDa
NCBI accession no.NM_012176.2
Quality Level100
shipped indry ice
species reactivityhuman
storage temp.−20°C
technique(s)western blot: 1 µg/mL
UniProt accession no.Q9UKT5
This product has met the following criteria: